The Danish Randomized Lung Cancer CT Screening Trial—Overall Design and Results of the Prevalence Round  Jesper H. Pedersen, MD, DrMSci, Haseem Ashraf,

Slides:



Advertisements
Similar presentations
Lung Adenocarcinoma with Ipsilateral Breast Metastasis: A Simple Coincidence? Hsu-Ching Huang, MD, Jen-Fan Hang, MD, Mei-Han Wu, MD, Teh-Ying Chou, MD,
Advertisements

The Efficacy and Safety of BI 2536, a Novel Plk-1 Inhibitor, in Patients with Stage IIIB/IV Non-small Cell Lung Cancer Who Had Relapsed after, or Failed,
Massive Bronchogenic Cyst Joseph B. Levin, BA, Chi Wan Koo, MD, Jessica S. Donington, MD Journal of Thoracic Oncology Volume 5, Issue 11, Pages
Primary Small Cell Carcinoma of the Esophagus Jima Lv, MD, Jun Liang, MD, Jinwan Wang, MD, Luhua Wang, MD, Jie He, MD, Zefen Xiao, MD, Weibo Yin, MD Journal.
A Hole in the Heart Journal of Thoracic Oncology
Neoplastic Fever Caused by Lung Cancer
The Danish Randomized Lung Cancer CT Screening Trial—Overall Design and Results of the Prevalence Round  Jesper H. Pedersen, MD, DrMSci, Haseem Ashraf,
Assessing the Impact of Incidental Findings in a Lung Cancer Screening Study by Using Low-dose Computed Tomography  Michael J. Kucharczyk, Ravi J. Menezes,
Successful Osimertinib Rechallenge in a Patient with T790M-Mutant Non–Small Cell Lung Cancer after Osimertinib-Induced Interstitial Lung Disease  Eisaku.
Hironori Yoshida, MD, Young Hak Kim, MD  Journal of Thoracic Oncology 
ALK FISH and IHC: You Cannot Have One without the Other
Assessing the Impact of Incidental Findings in a Lung Cancer Screening Study by Using Low-dose Computed Tomography  Michael J. Kucharczyk, Ravi J. Menezes,
Phase II Trial of Weekly Dose-Dense Paclitaxel in Extensive-Stage Small Cell Lung Cancer: Cancer and Leukemia Group B Study 39901  Stephen L. Graziano,
Electronic Updates for JTO Readers
Hedgehog Signaling Pathway and Lung Cancer
Surgical Treatment for Octogenarians with Lung Cancer: Results from a Population- Based Series of 124 Patients  Hes A.P. Brokx, MD, Otto Visser, MD, PhD,
Tracheoesophageal Fistula Associated with Bevacizumab 21 Months after Completion of Radiation Therapy  Elizabeth Gore, MD, Adam Currey, MD, Nicholas Choong,
Hironori Yoshida, MD, Young Hak Kim, MD  Journal of Thoracic Oncology 
The International Association for the Study of Lung Cancer International Staging Project on Lung Cancer  Peter Goldstraw, MB, FRCS, John J. Crowley, PhD 
Frank Detterbeck, MD  Journal of Thoracic Oncology 
Neoplastic Fever Caused by Lung Cancer
Successful Treatment with Erlotinib after Gefitinib-Induced Severe Interstitial Lung Disease  Masayuki Takeda, MD, PhD, Isamu Okamoto, MD, PhD, Chihiro.
Effective Treatment with Icotinib in Primary Adenoid Cystic Carcinoma of the Lung with Liver Metastasis  Zhengbo Song, MD, Wei Wu, MD, Yiping Zhang, MD 
George Blumenschein, MD, John V. Heymach, MD, PhD 
Lung Cancer Screening and Video-Assisted Thoracic Surgery
Jeffrey Bradley, MD, Issam El Naqa, PhD  Journal of Thoracic Oncology 
Association between Congenital Lung Malformations and Lung Tumors in Children and Adults: A Systematic Review  Arianna Casagrande, MD, Federica Pederiva,
A Hole in the Heart Journal of Thoracic Oncology
A Lung Cancer Responding to Hormonal Therapy
Pembrolizumab-Induced Encephalopathy: A Review of Neurological Toxicities with Immune Checkpoint Inhibitors  Sophie Feng, M.B.B.S., Jermaine Coward, PhD,
Richard J Gralla, MD, Frank Griesinger, MD, PhD 
Clinicopathological Characteristics of Screen-Detected Lung Cancers
Nivolumab-Induced Acute Diabetes Mellitus and Hypophysitis in a Patient with Advanced Pulmonary Pleomorphic Carcinoma with a Prolonged Tumor Response 
Elizabeth Cathcart-Rake, MD, Ariel Lopez-Chavez, MD, MS 
Jennifer L. Dallas, MD, Michael A. Jantz, MD, Judith L
Nasion Swelling as the Presenting Symptom of Lung Adenocarcinoma
Mitotic Inhibitors Journal of Thoracic Oncology
A Translational View of the Molecular Pathogenesis of Lung Cancer
Mirror Mirror on the Wall, Who Is the Fairest of Them All
EGFR delE709_T710insD: A Rare but Potentially EGFR Inhibitor Responsive Mutation in Non–Small-Cell Lung Cancer  Allison Ackerman, MD, Michael A. Goldstein,
Jennifer S. Temel, MD, William F. Pirl, MD, Christopher J
Gemcitabine in Brief versus Prolonged Low-Dose Infusion, both Combined with Cisplatin, for Advanced Non-small Cell Lung Cancer: A Randomized Phase II.
Pulmonary Metastasectomy in Breast Cancer
Phase I Study of Lenalidomide in Solid Tumors
T4 or MI? Journal of Thoracic Oncology Volume 6, Issue 3, (March 2011)
Maintenance Therapy and Advanced Non–Small-Cell Lung Cancer: A Skeptic's View  Martin J. Edelman, MD, Thierry Le Chevalier, MD, Jean-Charles Soria, MD,
Two Generations of Light/Never-Smokers With Advanced Adenocarcinoma of the Lung with Durable Responses to Erlotinib  Nathan A. Pennell, MD, PhD, Lihong.
Jie Huang, Juan Peng, Linlang Guo, MD, PhD 
Should Never-Smokers at Increased Risk for Lung Cancer Be Screened?
Antiangiogenesis Induced Tumor Cavitation in Lung Cancer
Phase II Trial of Paclitaxel, Carboplatin, and Topotecan with G-CSF Support in Previously Untreated Patients with Extensive Stage Small Cell Lung Cancer:
Genetic Changes in Squamous Cell Lung Cancer: A Review
Ethnic Differences in the Management of Lung Cancer in New Zealand
Roger Hakimian, MD, Hongbin Fang, PhD, Leno Thomas, MD, Martin J
European Lung Cancer Conference (ELCC) 2016 Organisation
Tetsuzo Tagawa, MD, Miyuki Takasu, MD, Teruyoshi Ishida, MD 
Metastatic Lung Cancer to the Pancreas
S-1 Treatment for Chemorefractory Thymic Carcinoma
Follow-Up of Small (4 mm or Less) Incidentally Detected Nodules by Computed Tomography in Oncology Patients: A Retrospective Review  Reginald F. Munden,
Collaterals Journal of Thoracic Oncology
IASLC 6th Latin American Conference on Lung Cancer
Tumor Lysis Syndrome in Limited-Stage Small-Cell Lung Cancer
Lung cancer randomized controlled trials should compare stereotactic body radiation therapy with observation, NOT surgery  Raja M. Flores, MD  The Journal.
Induction Therapy For Locally Advanced Thymoma
A Randomized, Phase II Trial of Two Dose Levels of Temsirolimus (CCI-779) in Patients with Extensive-Stage Small-Cell Lung Cancer Who Have Responding.
Rogerio C. Lilenbaum, MD, John Cashy, PhD, Thomas A
A Review of First-Line Treatment for Small-cell Lung Cancer
Mark A. Socinski, MD  Journal of Thoracic Oncology 
Robert Comis, MD, The Passing of a “Lung Man”
Ana Luque, MD, Edurne Arriola, MD, PhD  Journal of Thoracic Oncology 
Presentation transcript:

The Danish Randomized Lung Cancer CT Screening Trial—Overall Design and Results of the Prevalence Round  Jesper H. Pedersen, MD, DrMSci, Haseem Ashraf, MD, Asger Dirksen, DrMSci, Karen Bach, MD, Hanne Hansen, MD, Phillip Toennesen, DrMSci, Hanne Thorsen, MD, John Brodersen, PhD, Birgit Guldhammer Skov, DrMSci, Martin Døssing, DrMSci, Jann Mortensen, DrMSci, Klaus Richter, PhD, Paul Clementsen, DrMSci, Niels Seersholm, DrMSci  Journal of Thoracic Oncology  Volume 4, Issue 5, Pages 608-614 (May 2009) DOI: 10.1097/JTO.0b013e3181a0d98f Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

FIGURE 1 Design of the Danish lung cancer screening trial (DLCST). QOL, quality of life questionnaires; Smok., questionnaires regarding smoking habits; CT, low-dose multidetector computed tomography. Journal of Thoracic Oncology 2009 4, 608-614DOI: (10.1097/JTO.0b013e3181a0d98f) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions